Drug Profile
Research programme: oxytocin analogues - UniQuest
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator University of Queensland
- Developer UniQuest; University of Queensland
- Class Analgesics
- Mechanism of Action Oxytocin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Pain in Australia (PO)
- 03 Aug 2016 Research programme: oxytocin analogues - UniQuest is available for licensing - http://uniquest.com.au/filething/get/12155/Oxytocin%20Agonist%20UniQuest.pdf
- 03 Aug 2016 Preclinical trials in Pain in Australia (PO)